乐普医疗(300003.SZ)：预计2025年净利润同比增长223.97%～385.95%

Core Viewpoint - Lepu Medical (300003.SZ) expects a net profit attributable to shareholders of 800 million to 1.2 billion yuan for 2025, representing a year-on-year growth of 223.97% to 385.95% [1] Financial Performance - The net profit after deducting non-recurring gains and losses is also projected to be between 800 million and 1.2 billion yuan, with a year-on-year increase of 261.29% to 441.93% [1] - The company's core business in cardiovascular interventional revenue has shown steady growth, while the retail channel inventory clearance in the pharmaceutical sector has been largely completed, resulting in double-digit revenue growth [1] Business Stability and Cash Flow - The traditional business foundation remains solid, providing stable profits and cash flow for the company [1] - The strategic emerging sectors, including innovative drugs and dermatology, have contributed to performance growth, with net cash flow from operating activities increasing by approximately 95% [1]